Related Experiment Video
Updated: Sep 26, 2025

08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.2K
Adherence to Therapy in Glaucoma Treatment-A Review
Alexandra-Cătălina Zaharia1, Otilia-Maria Dumitrescu1, Mădălina Radu1
1Department of Ophthalmology, "Dr. Carol Davila" Central Military Emergency Hospital, 010825 Bucharest, Romania.
Journal of Personalized Medicine
|April 23, 2022
Summary
Glaucoma medication adherence is crucial for preventing vision loss. This study reviews methods to measure and improve patient adherence to glaucoma therapy, emphasizing patient education and personalized care.
Area of Science:
- Ophthalmology
- Public Health
- Patient Adherence Research
Background:
- Glaucoma is a leading cause of irreversible blindness globally.
- Effective treatment relies on topical ocular hypotensive eyedrops.
- Poor medication adherence affects up to 50% of glaucoma patients, hindering treatment benefits.
Purpose of the Study:
- To synthesize methods for measuring patient adherence to glaucoma therapy.
- To review interventions aimed at improving glaucoma medication adherence.
- To emphasize a patient-centered approach in managing chronic glaucoma.
Main Methods:
- Literature review of studies measuring glaucoma medication adherence.
- Analysis of interventions designed to enhance patient compliance.
- Focus on patient education and incorporating patient perspectives.
Main Results:
- Identified various barriers to adherence, including medication type, physician-patient communication, and patient behavior.
- Highlighted the link between non-adherence and disease progression.
- Synthesized diverse adherence measurement techniques and intervention strategies.
Conclusions:
- Improving glaucoma medication adherence is essential for preserving vision.
- A patient-centered strategy, including education and understanding patient views, is key.
- Further research into effective adherence interventions is warranted.
Related Concept Videos
Open Angle Glaucoma: Treatment
708
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
708
Angle Closure Glaucoma: Treatment
832
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
832
Glaucoma: Overview
910
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
910
Drug Therapy
108
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
108
Diabetes: Management and Pharmacotherapy
424
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
424

